Q2 EPS Estimate for Kyverna Therapeutics Raised by Analyst
Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) – Leerink Partnrs boosted their Q2 2025 earnings per share (EPS) estimates for Kyverna Therapeutics in a research note issued on Tuesday, May 13th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings of ($0.87) per share for the quarter, up from their prior […]
Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) – Leerink Partnrs boosted their Q2 2025 earnings per share (EPS) estimates for Kyverna Therapeutics in a research note issued on Tuesday, May 13th. Leerink Partnrs analyst T. Smith now forecasts that the company will post earnings of ($0.87) per share for the quarter, up from their prior […]
